Flatiron Health Announces New Partnership in the UK
Flatiron helps to fill this gap by curating high-quality, real-world evidence (RWE) derived from aggregated, de-identified patient information captured during routine care.
- Flatiron helps to fill this gap by curating high-quality, real-world evidence (RWE) derived from aggregated, de-identified patient information captured during routine care.
- The UK announcement comes at a time of significant international expansion for Flatiron.
- Flatiron International subsidiaries in Japan, Germany, and the UK are partnering with hospitals and health networks in RWD collaborations through Flatiron's local teams and infrastructure, ensuring that strict legal and regulatory requirements are met in all locations.
- “Each Flatiron International partnership is designed to help local healthcare providers and partners generate and utilize high-quality RWD to advance oncology research and care,” said Nathan Hubbard, Senior Vice President, Flatiron’s Head of Corporate Development and Flatiron International.